5
300 J . Org. Chem., Vol. 64, No. 14, 1999
Notes
Sch em e 1
logue (4b) was observed, and the product ratio was found
to be solvent dependent. Interestingly, either methylene
chloride or 1,2-dichloroethane as reaction solvent mini-
mized the formation of the alkene 4b, while performing
the reaction in toluene or acetonitrile produced this
material in up to 50% yield. In contrast to 3a , 3b was
stable to mild acid and base. When nonracemic 3b was
heated in concentrated HCl, the phenyl carbamate was
removed and the pyridyl chloride was racemized giving
intermediate 5. Basic workup of the reaction allowed
racemic 2 to be isolated in 87% yield [based on starting
solvents, and the chemical shifts are reported in ppm downfield
from tetramethylsilane, solvent (CDCl
3
δ
C
) 77.00, δ
H
) 7.25;
) 3.30)
DMSO-d ) 39.43, δ ) 2.5; CD OD δ
6
δ
C
H
3
C
) 49.05, δ
H
or added tetramethylsilane served as internal references. Optical
rotations were obtained at 589 nm (sodium D line) using a 1.9
dm cell at 20 °C. Chiral gas chromatographic separations were
conducted on a 20 m × 0.25 mm capillary column coated with
permethylated hydroxypropyl â-cyclodextrin phase at 130 °C
under isothermal conditions with a flow rate of 3.0 mL/min
(carrier gas He), using flame ionization detection.
P h en yl N-{4-Ch lor o-4-[3-(5-br om op yr id in yl)]bu tyl}-N-
m eth ylca r ba m a te (3b). A solution of 2 (60% ee favoring the
R-isomer) (60.2 g, 0.250 mol) was dissolved in dry CH Cl (200
2
2
(R)-enriched 2] over the three steps, and this was
mL) while stirring at ambient temperature. Phenyl chlorofor-
mate (32.7 mL, 0.26 mol) was added via syringe over 30 min,
and the mixture was stirred at room temperature for 3 h. Water
sufficiently pure to use in an optimized classical resolu-
tion procedure.
(10 mL) was added and the solution concentrated in vacuo to
give 3b as a viscous opaque brown oil (108 g). This material was
carried on to the next step without further purification. A portion
of this material was purified by chromatography on silica eluting
Con clu sion
In summary, a procedure for the racemization of (R)-
enriched 2 was devised. This protocol constitutes a novel
use of chloroformate-induced ring opening and halogen
exchange-mediated racemization of substituted pyrroli-
dine derivatives. The method promises to significantly
increase yields obtainable in the resolution sequence and
highlights key differences in reactivity between pyridine
ring substituted and unsubstituted nicotine derivatives.
In view of the recent surge of interest in nicotine
analogues as potential therapeutic agents, the methodol-
ogy described herein should prove to be of utility in the
2 2
with CH Cl :MeOH 98:2 to give a transparent oil. This com-
pound exists as rotamers; pairs of signals at δ 4.9 and 3.0
coalesce in 1H NMR at 52 °C (Figure 1). 1H NMR at 22 °C
3
(CDCl ) δ 8.62 (m, 1H), 8.52 (m, 1H), 7.90 (m, 1H), 7.36 (m, 2H),
7.20 (m, 1H), 7.08 (m, 2H), 4.98 and 4.89 (app dd, J ) 5,9 Hz,
1
1
1
1
H), 3.51 and 3.38 (m, 2H), 3.08 and 3.00 (s, 3H), 2.11 (m, 2H),
.87 (m, 1H), 1.75 (m, 1H); 13C NMR at 22 °C (CDCl
) δ 155.0,
3
51.2 (app d, J ) 6 Hz), 150.9, 150.7, 146.3 (app d, J ) 4 Hz),
39.0, 138.7, 137.1 (app d, J ) 4 Hz), 129.3 (app d, J ) 4 Hz),
25.3 (app d, J ) 7 Hz), 121.6, 120.8 (app d, J ) 5 Hz), 59.0,
1
1
8
53.4, 48.1, 47.8, 36.7, 34.8, 34.3, 25.3, 24.6; [R]
EtOH). Anal. Calcd for: C, 51.34; H, 4.56; N, 7.04. Found: C,
D
) -20° (c ) 5,
5
1.36; H, 4.59; N, 7.06.
preparation of a variety of novel nicotinic agonists and
antagonists.10
R a cem ic 5-Br om o-3-(1-m et h yl-2-p yr r olid in yl)p yr id in e
(
2). 5-Bromo-3-(1-chloro-4-(methyl(phenoxycarbonyl)amino)bu-
tyl)pyridine (3b) (88 g crude) was taken up in 10 M HCl (600
mL) and heated at reflux (internal temperature 105 °C) for 6 h.
The solution was made basic by the addition of NaOH (500 mL
of a 40% solution) while cooling with a dry ice-acetone bath to
maintain temperature below 50 °C. This mixture was extracted
Exp er im en ta l Section
Gen er a l. All reactions, unless otherwise noted, were con-
ducted under an inert atmosphere. Purchased reagents and
solvents were used as received. Column chromatography was
performed on silica gel (35-70 µm). Melting points were obtained
2 2 2 4
with CH Cl (1.2 L) and then dried over Na SO and concen-
trated in vacuo. This material was purified by filtration through
silica eluting with EtOAc:hexane 50:50 w 100:0 to give 2 as a
transparent golden oil (43.6 g, 87% from starting (R)-2) and was
shown to be racemic and identical to an authentic sample of 2.
1
in unsealed capillaries and are uncorrected. H NMR (300 MHz)
1
3
and C NMR (75 MHz) spectra were recorded in the indicated
(
10) Holladay, M. W.; Dart, M. J .; Lynch, J . K. J . Med. Chem. 1997,
4
0 (26), 4169-4194.
J O990152G